Her2-negative breast cancer Clinical Trials

Delta Trials tracks 141 clinical trials for Her2-negative breast cancer in its publicly accessible dataset. Among the listed trials, 59 open for participant enrollment and 31 trials have reached completion. This research is carried out at 1,078 clinical sites around the world. An additional 51 trials have active registrations outside the recruiting and completed categories. Since 2020, 17 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.